Between 1968 and 1984 liver resection with curative attempt was performed in 22 patients with hilar cholangiocarcinoma. Right lobectomy was performed in 4 patients, extended right lobectomy in 7, left lobectomy in 8, and excision of the median segment of the left lobe (segment IV) in 3. Bilioenteric continuity was restored by hepatocholedochostomy in 17 patients and hepatojejunostomy in 4. (One patient had external transhepatic catheter drainage and no internal bile drainage). Operative mortality rate was 27% and caused by excessive intraoperative bleeding, sepsis, or liver insufficiency. Postoperative complications occurred in 57% of patients surviving the operation and were due mainly to leakage from the hepatocholedochostomy. Median survival was 6 months, and one third of the patients survived I year. Three patients survived 10 years and were among the four patients in whom a tumor-free resection margin was obtained (one of them died in the postoperative phase). It is concluded that resection of hilar cholangiocarcinoma may give long-term survival if a free resection margin is obtained. The importance of a free resection margin indicates that surgery should be aggressive and include liver resection. The Cape Town group takes the opposite view point, namely that these lesions are rarely resectable for cure and reports 21 patients seen over 14 years which were treated primarily with operative tumour dilatation and U-tube insertion. External radiation was used in one half of those in which the tube was inserted. The early post-treatment mortality rate was 19%, and the median survival overall was just over one year. Three patients survived beyond five years, however in two longterm survivors, the diagnosis ofcancer was not proven histologically. Of note, there was no difference in the survival rates between patients treated by the U-tube and those without, making it difficult to accept the recommendation that the U-tube is the preferred method of treatment. Because of the selection of good risk patients for radiation therapy, its value was not possible to assess from this report. This method of treatment is considerably easier to perform than resection and the authors note that since their first report, their referral in numbers has declined. This may be the result of patients being treated primarily by intubation elsewhere without consideration being given to the option of resection.
Our own experience 3 with proximal biliary cancer suggests that resection of the tumour including liver resection when required, can be carried out with low mortality.
We have previously reported resecting 12 of 54 hilar tumours seen between 1969 and 1984. Adjuvant external beam radiation therapy was used in 9 and median survival in this group of patients is now 22 months. Three of these patients have survived five years. Operative mortality of resection of proximal tumours in our study was 8% and median survival of patients not resected was 6 months.
Our current approach is therefore to resect patients where possible. It is our belief and that of others that this is the most likely method of treatment to result in long term survival or cure. The mortality associated with combined liver resection suggests that this should be carried out only when necessary to remove all gross tumour.
In assessing other methods of treatment regarding palliation or longterm survival, it has been our experience that operative bypass provides better palliation, in that the incidence of cholangitis is much less than the transhepatic tubes-either transhepatic single tubes or U-tubes as described by Dr. Terblanche. We have not however documented any difference in survival time between operative bypass and intubation.
Treatment techniques both surgical and radiological are still evolving in this disease. It is important that these patients be seen in centers which have the expertise both radiological and surgical, to provide whatever therapy might be indicated from palliative to potentially curative. It is also important that treatment modalities be evaluated prospectively through controlled trials. Because of the infrequency with which these tumours are seen, it will be necessary to carry out multi-centered randomized trials to assess the relative indications and roles of radical surgical resection versus conservative management by bypass or intubation, as well as the role of radiation, chemotherapy and the possible role of liver transplantation. Readers are also encouraged to contact the Editor of this section with suggestions on papers to be included. An authority in the field will be asked to comment in a signed short essay or editorial on the selected papers. Both the original abstract (or summary of the abstract) and the expert essay will be published.
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